On 21 April 2026, All.Can International Executive Director Madalina Iamandei joined the panel on ‘Beating Cancer from the Start’ at EFPIA’s Europe’s Choice conference in Brussels, one of the most significant health policy gatherings of the spring.
The EFPIA conference, titled Europe’s Choice: Investing in Sustainable Health Systems, brought together senior voices from European institutions, national health ministries, patient organisations and the pharmaceutical industry to examine the investment choices facing European health systems in the years ahead. European Commissioner for Health Olivér Várhelyi delivered closing remarks, reflecting the event’s significance in the current EU health policy cycle.
Madalina joined panelists from Digestive Cancers Europe, the European Cancer Organisation, the Latvian Ministry of Health and Pfizer International Oncology to make the case that investment in cancer care and the sustainability of health systems are inseparable questions. Efficient, person-centred care is not a cost driver. It is a structural response to one of the most pressing challenges facing European health systems: how to deliver better outcomes for more people with finite and constrained resources.
The panel discussion drew on All.Can’s work with the EFPIA Oncology Platform on EU cancer screening implementation across six countries, as well as on the evidence base in All.Can’s report Implementing Person-Centred Cancer Care to Improve Outcomes, Experiences and Efficiency. Madalina highlighted the importance of co-designed screening programmes, where patients and communities are active participants in how screening is designed and delivered, as a concrete, replicable model for making cancer prevention both more equitable and more effective. The Basque Country’s approach to collaborative screening design, which draws on All.Can’s work with EFPIA Oncology Platform, was cited as one such example.
At the core of All.Can’s contribution to the Brussels debate is a straightforward but demanding argument: the transition from volume-based to value-based care requires more than good intentions. It requires measurement frameworks that track what matters to people with cancer, care pathways designed around the person rather than the institution, and financing models that reward coordination and continuity alongside clinical activity.
With the 2028 to 2034 EU budget negotiations under way, and Europe’s Beating Cancer Plan under formal assessment, the policy window for embedding these principles into EU health investment is open. All.Can International will continue to make the evidence-based case for using it.
Find out more
Read All.Can International’s report Implementing Person-Centred Cancer Care to Improve Outcomes, Experiences and Efficiency at allcan.org. Learn more about the EFPIA Oncology Platform collaboration at all-can.org/news